Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04537390

Anti-mullerian Hormone Levels in Healthy Females

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Erin Rowell · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to have a better understanding of the normal blood levels of AMH in females from 0-18 years of age and how the blood AMH levels correspond to a female's reproductive development.

Detailed description

Anti-mullerian hormone (AMH) is a chemical in the body that is found in the blood that can estimate the ability of a female to have her own children. It is widely used in adult female cancer patients to predict the onset of menopause and/or the inability to have children that can be associated with chemotherapy and/or radiation treatment. Normal blood levels of AMH are better understood in adults than in children and adolescents. The purpose of this study is to have a better understanding of the normal blood levels of AMH in females from 0-18 years of age and how the blood AMH levels correspond to a female's reproductive development. With a better understanding of normal AMH levels in children, we may be able to better assess a girl's risk of not being able to have children if she is a cancer patient, and may be able to offer her and her family options to increase the chances of having her own children.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBlood sample collectionBlood samples are collected for diagnostically assessing how the blood AMH levels correspond to a female's reproductive development

Timeline

Start date
2016-07-19
Primary completion
2030-12-01
Completion
2030-12-01
First posted
2020-09-03
Last updated
2024-11-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04537390. Inclusion in this directory is not an endorsement.